GAN
GAN (gigaxonin; also known as GAN1, KLHL16 and GIG) is a cytoskeletal BTB/kelch repeat protein that contributes to neurofilament architecture. It may act as a substrate-specific adapter for an E3 ubiquitin-protein ligase complex, and defects in the GAN gene cause giant axonal neuropathy. Browse Assay Genie's current range of GAN research reagents below, or read on for the biology behind the target.
GAN is a probable cytoskeletal component that, directly or indirectly, plays an important role in neurofilament architecture. It may also act as a substrate-specific adapter of an E3 ubiquitin-protein ligase complex, which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Through this route, gigaxonin controls the degradation of TBCB, MAP1B and MAP1S, and it is critical for neuronal maintenance and survival.
The GAN gene encodes a member of the cytoskeletal BTB/kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. HGNC places it in the Kelch like and BTB domain containing gene groups, and also lists it among the microRNA protein coding host genes. The protein localises to the cytoplasm and the cytoskeleton. A mouse ortholog, Gan, is recorded, which makes it relevant to comparative studies of neuronal cytoskeletal biology.
The gene was named for its disease association: defects in GAN are a cause of giant axonal neuropathy, and the previous HGNC name was giant axonal neuropathy (gigaxonin). Researchers studying GAN protein often focus on neurofilament organisation and on ubiquitin-dependent turnover of microtubule-associated proteins. Alternative designations include GAN1, KLHL16 and GIG.
GAN plays an important role in neurofilament architecture, so it is a focus for studies of neuronal cytoskeletal organisation.
GAN may act as a substrate adapter of an E3 ubiquitin ligase complex that directs target proteins to proteasomal degradation.
Gigaxonin controls degradation of MAP1B and MAP1S and is critical for neuronal maintenance and survival.
Defects in the GAN gene cause giant axonal neuropathy, making the protein central to studies of this disorder.
GAN is a probable cytoskeletal component important for neurofilament architecture. It may act as a substrate-specific adapter of an E3 ubiquitin-protein ligase complex, controlling proteasomal degradation of TBCB, MAP1B and MAP1S, and it is critical for neuronal maintenance and survival.
The HGNC full name is gigaxonin, and the previous name was giant axonal neuropathy (gigaxonin). Aliases and previous symbols include GAN1, KLHL16 and GIG. KLHL16 reflects its membership of the Kelch-like gene group.
Defects in the GAN gene cause giant axonal neuropathy. A mouse ortholog, Gan, is recorded, so rodent models can be used to study it. Check the datasheet of any product for its validated reactivity.
Substrates of gigaxonin-mediated degradation and other cytoskeletal and ubiquitin pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9H2C0; product specifications from Assay Genie datasheets.